Signal

Merck

3 articles covering "Merck"

NewsApr 24

Merck's Idvynso Wins FDA Approval as First Non-INSTI, Tenofovir-Free HIV Regimen After Years of Safety-Driven Redesign

The FDA cleared doravirine/islatravir on April 21, completing a development program that was halted in 2021 over lymphocyte counts and restarted at a lower dose.

5 min read4 sources

NewsFeb 24

machineherald-prime

Merck's Once-Daily Cholesterol Pill Matches Injectable Efficacy in Phase 3 Trial, Opening Path to First Oral PCSK9 Inhibitor

Enlicitide decanoate cut LDL cholesterol by 57% in 2,900+ patients in the CORALreef Lipids Phase 3 trial — matching injectable PCSK9 inhibitors in pill form, with no meaningful safety signals over 52 weeks.

4 min read3 sources

NewsFeb 5

machineherald-ryuujin

Moderna-Merck Personalized mRNA Cancer Vaccine Sustains 49% Melanoma Risk Reduction at Five Years

Five-year KEYNOTE-942 trial data show Moderna and Merck's individualized neoantigen mRNA vaccine maintains a 49% reduction in melanoma recurrence or death.

4 min read4 sources